1996
DOI: 10.1097/00006676-199603000-00015
|View full text |Cite
|
Sign up to set email alerts
|

Combined Analysis of Expression of c-evbB-2, Ki-67 Antigen, and Tenascin Provides a Better Prognostic Indicator of Carcinoma of the Papilla of Vater

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…15 Annexin II is present in the cell cytoplasm in a monomeric form in which it forms a complex with calpactin I light chain (p11), a member of the S-100 family of EF hand proteins. 38,42,44 An- nexin II has been identified as a high-affinity receptor for ECM glycoproteins, including an alternatively spliced domain of tenascin-C. 33,34 Because this alternatively spliced domain promotes tumor cell migration, 33,34 we hypothesized that the role of annexin II overexpression in the spread of colorectal carcinoma may be mediated in part through the binding of tenascin-C. 55,56 Tetrameric annexin II [(Annexin II) 2 -(p11) 2 ] is localized to the cell membrane.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…15 Annexin II is present in the cell cytoplasm in a monomeric form in which it forms a complex with calpactin I light chain (p11), a member of the S-100 family of EF hand proteins. 38,42,44 An- nexin II has been identified as a high-affinity receptor for ECM glycoproteins, including an alternatively spliced domain of tenascin-C. 33,34 Because this alternatively spliced domain promotes tumor cell migration, 33,34 we hypothesized that the role of annexin II overexpression in the spread of colorectal carcinoma may be mediated in part through the binding of tenascin-C. 55,56 Tetrameric annexin II [(Annexin II) 2 -(p11) 2 ] is localized to the cell membrane.…”
Section: Discussionmentioning
confidence: 99%
“…[32][33][34][35][36] Stromal tenascin-C overexpression has been demonstrated in malignant tumors of the skin, breast, salivary gland, lung, esophagus, pancreas, small intestine, and colon [36][37][38][39][40][41][42][43][44][45] and has been suggested to be a prognostic marker for a number of human carcinomas. 38,42,44 Tenascin-C has multiple isoforms as a result of alternative splicing. 26 Annexin II is a high affinity receptor for an alternatively spliced segment of tenascin-C, 33,34 and ligand binding promotes tumor cell migration.…”
mentioning
confidence: 99%
“…With regard to the proliferation marker, MIB1, the results of our own investigation are compatible with those reported by Minimo et al [23] who, in a study published in 1996, described a strong correlation of the Ki-67 antigen expression rate with the progression of malignancy of ampullary lesions. Vaidya et al [24] observed a decrease in survival time with increasing Ki-67 positivity.…”
Section: Originalarbeitmentioning
confidence: 96%
“…Tenascin C concentrations have been associated with tumour recurrence and prognosis, although the findings are contradictory. [10][11][12][13][14][15] In laryngeal and hypopharyngeal cancers, the accumulation of tenascin in the blood vessels is an indicator of an unfavourable prognosis; it correlates with metastasis, early tumour recurrence, and a lethal outcome. 14 In breast cancer, the expression of tenascin C in the invasion border of the tumour is a predictor of local and distant recurrence.…”
mentioning
confidence: 99%